Castle Biosciences Wins NY Approval for AdvanceAD-Tx Test
FRIENDSWOOD, Texas, July 14, 2026 Castle Biosciences, Inc. has announced that its AdvanceAD-Tx™ test has received assay approval from...
AdvanceAD-Tx
Advertisement
Castle Biosciences Wins 2026 Genomics Innovation Award
FRIENDSWOOD, Texas, May 12, 2026 Castle Biosciences announced that its AdvanceAD-Tx™ gene expression profiling test received the prestigious 2026...
Alkermes Reports Strong Phase 3 LUMRYZ Trial Data
DUBLIN, Ireland, May 12, 2026 Alkermes announced positive topline results from the pivotal REVITALYZ Phase 3 clinical trial evaluating...
AdvanceAD-Tx Predicts JAK Response in Dermatitis
FRIENDSWOOD, Texas, Feb. 19, 2026 — Castle Biosciences announced prospective clinical validation data published in the Journal of the...
Advertisement
